Simpler Grants.gov #HT942526PRCRPIPA

FY26 Peer Reviewed Cancer Research Program (PRCRP) Impact Award Solicitation

The Department of the Army, via the U.S. Army Medical Research Acquisition Activity (USAMRAA), is inviting applications for the FY26 Peer Reviewed Cancer Research Program (PRCRP) Impact Award. - Managed by the Congressionally Directed Medical Research Programs (CDMRP) under Assistance Listing 12.420 (Military Medical Research and Development) - Supports mature cancer research projects with potential for near-term impact on clinical care, especially within the Military Health System (MHS) - Research must address congressionally directed FY26 PRCRP Topic Areas - Applicants must provide preliminary data to demonstrate feasibility - Clinical trials are permitted - Single or partnering Principal Investigator (PI) options available, with specific requirements for each - Funding details: - Approximately $45 million available for up to 30 awards (max $1.5 million each, up to 3 years) - Additional $28 million for up to 14 Partnering PI Option awards (max $2 million each) - No specific OEMs or vendors are named, as this is a research grant opportunity - Place of performance and contracting office: USAMRAA (Department of the Army) - Unique requirements: - Projects must demonstrate potential for near-term impact on cancer care within the MHS - Preliminary data required - Both single and collaborative (partnering PI) applications accepted

Description

The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Impact Award supports mature research projects that aim to have a near-term impact on clinical cancer care within congressionally directed FY26 PRCRP Topic Areas. The program requires applications to include preliminary data demonstrating study feasibility and allows for clinical trials. It supports projects led by a single Principal Investigator or two partnering PIs, with specific application requirements for each. The funding is intended to advance knowledge in cancer research, patient care, and treatment options within the Military Health System (MHS).

View original listing